GGrantIndex
← Leaderboards

Samir M Hanash

University Of Michigan At Ann Arbor

Google Scholar ↗PubMed ↗ORCID ↗
$22,144,784
Attributed
$25,228,637
Total exposure
15
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.1M · FY2005–25
$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$32,425,622 · 16

By mechanism

U01$20,599,154 · 6
U19$7,300,693 · 2
P01$2,934,963 · 2
R21$1,550,812 · 4
R13$40,000 · 1
M01$0 · 1

Top collaborators

Most similar at University Of Michigan At Ann Arbor

Same institution · by research overlap

Others in their field

Top investigators on “Proteomics”

Research focus

ProteomicsBaseProteinsEarly DiagnosisDiagnosisTumor AntigensSamplingMalignant NeoplasmsMalignant Neoplasm Of LungValidationBiomarkerDiagnosticCohortTissuesAutoantibodiesResearch PersonnelValidation StudiesLungTechnologyBloodResourcesTumorMouse ModelCell Line

Grant awards (58)

Clinical Validation Center for Lung Cancer Early Detection$2,077,743
U01 · FY2025 · CA · contact PI
Clinical Validation Center for Lung Cancer Early Detection$986,935
U01 · FY2024 · CA · contact PI
Clinical Validation Center for Lung Cancer Early Detection$1,023,059
U01 · FY2023 · CA · contact PI
Clinical Validation Center for Lung Cancer Early Detection$792,272
U01 · FY2022 · CA · contact PI
Prostate cancer-associated SPOP mutations modulate innate immune response and immune checkpoint therapy$185,552
R21 · FY2022 · CA
Development of Risk and Early Detection Biomarker for Small Cell Lung Cancer$455,339
U01 · FY2021 · CA · contact PI
Prostate cancer-associated SPOP mutations modulate innate immune response and immune checkpoint therapy$227,205
R21 · FY2021 · CA
Development of Risk and Early Detection Biomarker for Small Cell Lung Cancer$517,386
U01 · FY2020 · CA · contact PI
Identifying Actionable Signatures of Duodenopancreatic Neuroendocrine Tumor Progression in MEN1$416,543
R21 · FY2020 · CA · contact PI
Development of Risk and Early Detection Biomarker for Small Cell Lung Cancer$491,462
U01 · FY2019 · CA · contact PI
Incorporating Biomarkers to Improve Lung Cancer Risk Prediction$651,841
U01 · FY2018 · CA · contact PI
Development of Risk and Early Detection Biomarker for Small Cell Lung Cancer$528,902
U01 · FY2018 · CA · contact PI
Incorporating Biomarkers to Improve Lung Cancer Risk Prediction$656,359
U01 · FY2017 · CA
Development of Risk and Early Detection Biomarker for Small Cell Lung Cancer$558,611
U01 · FY2017 · CA · contact PI
Incorporating Biomarkers to Improve Lung Cancer Risk Prediction$692,318
U01 · FY2016 · CA
Affinity Based Strategies to Fast Track Development of Colon Cancer Biomarkers$584,841
U01 · FY2014 · CA
Affinity Based Strategies to Fast Track Development of Colon Cancer Biomarkers$576,207
U01 · FY2013 · CA
Preventive Interventions Leadership U01$342,610
U01 · FY2013 · CA · contact PI
Affinity Based Strategies to Fast Track Development of Colon Cancer Biomarkers$610,846
U01 · FY2012 · CA
Preventive Interventions Leadership U01$388,513
U01 · FY2012 · CA · contact PI
CONFIRMATION STUDIES OF BLOOD BASED BIOMARKERS OF RISK FOR BREAST CANCER$191,400
R21 · FY2012 · CA · contact PI
Affinity Based Strategies to Fast Track Development of Colon Cancer Biomarkers$657,567
U01 · FY2011 · CA
Preventive Interventions Leadership U01$495,793
U01 · FY2011 · CA · contact PI
CONFIRMATION STUDIES OF BLOOD BASED BIOMARKERS OF RISK FOR BREAST CANCER$229,680
R21 · FY2011 · CA · contact PI
Affinity Based Strategies to Fast Track Development of Colon Cancer Biomarkers$658,130
U01 · FY2010 · CA
Preventive Interventions Leadership U01$412,163
U01 · FY2010 · CA · contact PI
Proteomics Biomarkers Development Laboratory$443,657
U01 · FY2009 · CA · contact PI
Preventive Interventions Leadership U01$410,020
U01 · FY2009 · CA · contact PI
Proteomics Biomarkers Development Laboratory$458,633
U01 · FY2008 · CA · contact PI
Core--Proteomic and Genomic Analyses$222,921
P01 · FY2008 · CA · contact PI
Proteomics Biomarkers Development Laboratory$572,408
U01 · FY2007 · CA · contact PI
Core--Proteomic and Genomic Analyses$221,509
P01 · FY2007 · CA · contact PI
Proteomics Biomarkers Development Laboratory$584,871
U01 · FY2006 · CA · contact PI
Core--Proteomic and Genomic Analyses$102,068
P01 · FY2006 · CA · contact PI
Proteomics Biomarkers Development Laboratory$585,214
U01 · FY2005 · CA
Core--Proteomic and Genomic Analyses$99,394
P01 · FY2005 · CA
Proteomics Biomarkers Development Laboratory$589,458
U01 · FY2004 · CA
TOWARDS A MOLECULAR CLASSIFICATION OF TUMORS$291,347
U19 · FY2004 · CA
Core--Proteomic and Genomic Analyses$96,578
P01 · FY2004 · CA
TOWARDS A MOLECULAR CLASSIFICATION OF TUMORS$1,954,505
U19 · FY2003 · CA
PROTEOMICS BIOMARKER DEVELOPMENT LABORATORY$552,087
U01 · FY2003 · CA
PROTEOMICS BIOMARKER DEVELOPMENT LABORATORY$450,001
U01 · FY2003 · CA
HUPO 2nd Annual World Congress Montreal 2003$40,000
R13 · FY2003 · HG
TOWARDS A MOLECULAR CLASSIFICATION OF TUMORS$2,032,480
U19 · FY2002 · CA
PROTEOMICS BIOMARKER DEVELOPMENT LABORATORY$494,626
U01 · FY2002 · CA
Analysis to enhance sensitivity for membrane proteins$150,216
R21 · FY2002 · CA
PROTEIN PATTERNS IN LEUKEMIC CELLS$0
M01 · FY2002 · RR
CORE--PROTEOMICS$0
U19 · FY2002 · CA
TOWARDS A MOLECULAR CLASSIFICATION OF TUMORS$1,476,272
U19 · FY2001 · CA
HUMAN MUTATION$1,116,724
P01 · FY2001 · CA
PROTEOMICS BIOMARKER DEVELOPMENT LABORATORY$779,892
U01 · FY2001 · CA
Analysis to enhance sensitivity for membrane proteins$150,216
R21 · FY2001 · CA
CORE--PROTEOMICS$0
U19 · FY2001 · CA
TOWARDS A MOLECULAR CLASSIFICATION OF TUMORS$1,442,381
U19 · FY2000 · CA
HUMAN MUTATION$1,075,769
P01 · FY2000 · CA
PROTEOMICS BIOMARKER DEVELOPMENT LABORATORY$519,390
U01 · FY2000 · CA
CORE--PROTEOMICS$103,708
U19 · FY2000 · CA
PROTEIN PATTERNS IN LEUKEMIC CELLS$0
M01 · FY2000 · RR